Botulinum toxin for axillary hyperhidrosis
- PMID: 25152343
- DOI: 10.1016/j.det.2014.06.013
Botulinum toxin for axillary hyperhidrosis
Abstract
Botulinum toxin is a safe and effective treatment option for axillary hyperhidrosis. Although its pathophysiology is not clear and somewhat controversial, the beneficial effect of neuromodulators in inhibiting localized sweating temporarily is well known. Before the procedure, correct identification of the affected area is mandatory to avoid wastage of drug and neglect of target areas, and to enhance efficacy, as the hyperhidrotic location may not match the hairy axillary region. Utilization of this medication, such as dilution and injection techniques, depends on medical experience and may have some variations, including methods to make the procedure as painless as possible.
Keywords: Axillary hyperhidrosis; Botox; Botulinum toxin; Excessive underarm sweating; Neuromodulators.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Botulinum toxin for hyperhidrosis of areas other than the axillae and palms/soles.Dermatol Clin. 2014 Oct;32(4):517-25. doi: 10.1016/j.det.2014.06.001. Epub 2014 Jul 28. Dermatol Clin. 2014. PMID: 25152345 Review.
-
Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.J Drugs Dermatol. 2011 Sep;10(9):1013-5. J Drugs Dermatol. 2011. PMID: 22052270 Review.
-
Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.J Am Acad Dermatol. 2013 Dec;69(6):960-4. doi: 10.1016/j.jaad.2013.08.002. Epub 2013 Sep 13. J Am Acad Dermatol. 2013. PMID: 24035554
-
[Botulinum toxin in the treatment of focal hyperhidrosis].Wien Klin Wochenschr. 2001;113 Suppl 4:36-41. Wien Klin Wochenschr. 2001. PMID: 15506051 Review. German.
-
Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.J Eur Acad Dermatol Venereol. 2012 Mar;26(3):314-8. doi: 10.1111/j.1468-3083.2011.04066.x. Epub 2011 Apr 15. J Eur Acad Dermatol Venereol. 2012. PMID: 21492253 Clinical Trial.
Cited by
-
Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.Medicina (Kaunas). 2022 Jun 16;58(6):813. doi: 10.3390/medicina58060813. Medicina (Kaunas). 2022. PMID: 35744076 Free PMC article. Review.
-
Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production.Dermatol Ther (Heidelb). 2020 Aug;10(4):707-720. doi: 10.1007/s13555-020-00397-5. Epub 2020 May 22. Dermatol Ther (Heidelb). 2020. PMID: 32445175 Free PMC article.
-
Brain functional changes in patients with botulism after illegal cosmetic injections of botulinum toxin: A resting-state fMRI study.PLoS One. 2018 Nov 28;13(11):e0207448. doi: 10.1371/journal.pone.0207448. eCollection 2018. PLoS One. 2018. PMID: 30485326 Free PMC article. Clinical Trial.
-
New trends in botulinum toxin use in dermatology.Dermatol Pract Concept. 2018 Oct 31;8(4):277-282. doi: 10.5826/dpc.0804a05. eCollection 2018 Oct. Dermatol Pract Concept. 2018. PMID: 30479855 Free PMC article.
-
Large eccrine angiomatous hamartoma: a novel clinical presentation of disease.J Dermatol Case Rep. 2015 Sep 30;9(3):58-61. doi: 10.3315/jdcr.2015.1211. eCollection 2015 Sep 30. J Dermatol Case Rep. 2015. PMID: 26512300 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
